semaglutide flow study ❇️Patients with obesity, type 2 #diabetes and chronic kidney disease are at high risk for kidney failure, cardiovascular events, and death. This study, the trial now published, evaluated treatment with (# Semaglutide Winning Streak Continues in
Description
Active Infections: Any active infection, regardless of the severity, is a temporary disqualifier
The cumulative incidence curves for depression began to diverge after approximately 2 months of followup (Figure 2), with the GLP1 RA group showing a consistently higher cumulative incidence throughout the remainder of the year
Interestingly, these effects were found to not be simply regulated through the control of the levels of insulin (123)
While increased medical surveillance in patients with DM or thyroid disorders may account for this trend, potential pathophysiological mechanisms do exist that might explain the development of thyroid disorders in patients with DM and also the increased risk for development of DM in individuals with thyroid disorders
however, indirect effects such as increased heart rate, gastrointestinal distress, or hypoglycaemia may provoke anxiety-like symptoms in susceptible individuals
